MedTrace Logo

STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia

NCT01693146 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-09-26

No results posted yet for this study

Summary

Evaluation of Safety and Efficacy of Short time TNI Treatment in Patients with COPD and hypercapnia.

Acute testing of oxygen demand using TNI vs. standard oxygen application in stable COPD patients with hypercapnia.

Conditions

Interventions

DEVICE

Nasal oxygen insufflation with a TNI® 20 oxy device

Nasal insufflation at a constant high flow of 15 L/min with oxygen addition starting at 0.5 L/min

DEVICE

Nasal insufflation of oxygen

Nasal insufflation of oxygen starting at at flow of 0.5 L/min.

Sponsors & Collaborators

  • TNI Medical AG

    collaborator INDUSTRY

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Christian M Kaehler, MD · Medical University Innsbruck

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Austria
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693146 on ClinicalTrials.gov